Introduction A brief resolved unexplained event (BRUE) describes an event associated with a change in muscle tone, color, respiration, and responsiveness that is unexplained after an appropriate examination. Some infants with higher risk BRUE may undergo endoscopy as part of their evaluation. Objective This retrospective study aimed to identify the endoscopic findings in infants who have experienced a higher risk BRUE. We also compared the characteristics, prenatal, natal, and postnatal risk factors between 23 infants who underwent endoscopic evaluation and 23 race-matched/sex-matched/term-matched/preterm-matched infants who did not undergo endoscopic evaluation. Methods This was a retrospective descriptive study. Infants were identified from a query of medical records using the ICD-10 code for BRUE (R68.13).
Introduction
Brief resolved unexplained events (BRUE) is a more precise term that applies to infants previously described as having apparent life-threatening events. BRUE is defined as a sudden, brief, and now resolved, episode occurring in an infant younger than 1 year. It is frightening to the observer, and the episode is characterized by (i) cyanosis or pallor, (ii) absent, decreased, or irregular breathing, (iii) change in tone (hypertonia or hypotonia), and (iv) altered level of responsiveness. Higher risk BRUE is a diagnosis based on the history and physical examination that suggests the need for further investigation and management [1] . The incidence of BRUE was described as 0.6-2.46 per 1 000 live births and 0.6-0.8% of all emergency visits for infants younger than 1 year [2] . Gastroesophageal reflux (GER) is one of the possible etiologic explanations for symptoms experienced by patients undergoing evaluation for possible BRUE. GER and milk soy protein intolerance (MSPI) are frequent disorders in infants. A possible association between GER and MSPI has been suggested [3] . Up to 40% of infants with GER are noted to have MSPI [4] .
Food allergies can be classified as immediate (IgE mediated) and late-onset (non-IgE mediated, mixed IgE, and cell mediated) reactions that can also be lifethreatening. Food allergies are distinguished from food intolerances. The food intolerances are nonspecific, nonallergic reactions that do not involve the immune system. Food intolerance is a delay in symptom onset, prolonged symptoms, and negative IgE serology [5] . Cow's milk protein allergy (CMPA) is the most common non-IgE immune-mediated food allergy in infants with an incidence of 2-3% in the first year of life [6] . There are several factors that affect the CMPA immunological mechanism, including genetics, dose of cow milk, frequency of consumption, age at first cow milk exposure, and cow milk transmission through breast milk [7] . There is not a single manifestation that is specific for CMPA. Many of its symptoms are of the skin but can also be of the gastrointestinal or respiratory tracts. Half of those diagnosed with CMPA have atopic eczema and 25-50% have some gastrointestinal symptoms [8] . CMPA rarely develops after 12 months of age and usually develops within 2 months after beginning cow's milk or soy [9] . The ESPGHAN guidelines recommend re-evaluation of infants every 6-12 months to assess if the patients have developed tolerance to cow's milk, and there was a resolution in 75% by 3 years and more than 90% by 6 years [10] .
There are some differences between CMPA and MSPI. One of the currently available cow's milk substitutes for infants is soy protein formula. Soybeans have been cultivated in Eastern countries for many centuries and were first used to feed US babies with cow's milk allergy in 1929 [11] . The general agreement is that a significant number of children with cow's milk protein intolerance develop soy protein intolerance when soy milk is used in dietary management. However, the American Academy of Pediatrics states that infants with IgE-associated symptoms of cow's milk allergy may benefit from a soy formula because the risk of cross-reactivity does not appear to be very high. The prevalence rate of soy protein allergy was reported to be 1.1%, compared with a 3.4% prevalence rate of CMPA [11] .
No single laboratory test is sensitive or specific enough to make a diagnosis of CMPA or MSPI. Esophagogastroduodenoscopy (EGD) and flexible sigmoidoscopy in conjunction with the evaluation of biopsy specimens may be considered for confirming a diagnosis of CMPA or MSPI. Some infants who experience a higher risk BRUE may undergo EGD and flexible sigmoidoscopy as part of their evaluation.
Objective
The objective of our study was to describe the clinical characteristics and endoscopic and histologic findings in infants with gastrointestinal symptoms who have experienced a higher risk BRUE.
Methods

Study population
Our study was a retrospective review of records of infants younger than 12 months who presented to University of South Alabama Children's and Women's Hospital with an admission diagnosis of BRUE from October 2015 to February 2017. The Institutional Review Board of the University of South Alabama approved this study.
Data collection
Infants were identified from an examination of medical records using the ICD-10 code for BRUE (R68.13). Initially, two investigators (C.J. and M.G.) each reviewed the electronic medical charts to ensure consistent data. Patients who were diagnosed with BRUE and who also underwent an EGD and flexible sigmoidoscopy between October 2015 and February 2017 were included in our study.
We investigated demographics, gestational age, chronic condition defined as underlying diseases (including congenital heart disease, genetic diseases, bronchopulmonary dysplasia, and pre-existing known GER or MSPI), initial presentation, admission history, formula feeding, weight/ length at admission, duration of hospitalization, and detailed information on the endoscopic and histologic findings. The definition of eosinophilia in duodenum and colon/rectum of our study was more than 10 eosinophils/ high power field and more than 5 eosinophils/high power field if the infant had already been on a hypoallergenic formula.
We also chose a control group from the infants who did not undergo endoscopy by matching the age, race, sex, and term/preterm status at birth. We investigated these characteristics; prenatal, natal, and postnatal risk factors; and endoscopic findings.
Endoscopy
Indications for endoscopy included investigations to identify the source of fecal occult blood or evaluation of an infant with unexplained crying or distressed behavior following the pediatric GER disease clinical practice guidelines. The patients were given nothing by mouth of formula or breast milk for 4 h with clear Pedialyte given until 2 h before the procedures (EGD and flexible sigmoidoscopy). ECG, blood pressure, and pulse oximetry were monitored through the procedures. Midazolam was given per rectum before the procedure for sedation. Cetacaine spray was administered topically to the pharynx before the procedures.
EGD and flexible sigmoidoscopy with biopsy were performed using standard techniques. Biopsies were obtained from the second portion of the duodenum, antrum, esophagus at 3 and 6 cm above the lower esophageal sphincter, sigmoid colon, and rectum for histopathologic evaluation. The same pediatric pathologist performed histological analysis.
Statistical analysis
All data collected were recorded in a clinical database. Software R (R Foundation for Statistical Computing, Vienna, Austria) was used for all statistical analyses. The quantitative data such as gestational age or weight were summarized using mean SD, and categorical data such as sex or presence/absence of a condition were summarized using percentages. Owing to small sample size in this study, Wilcoxon's test was used to compare the distributions of quantitative outcomes for the two groups and Fisher's exact test was used to compare the incidence rates of categorical variables in the two groups. Significance level of 0.05 was used to determine the significance of results.
Results
Initial data showed 23 (19.3%) infants presenting with higher risk BRUE also had undergone an EGD and flexible sigmoidoscopy from a total 119 infants with BRUE from October 2015 to February 2017. Most were female (57%) with a mean age at BRUE presentation of 2.73 2.76 months. The manifestations of BRUE were apnea (20/23; 87%), cyanosis (10/23; 43.5%), choking (5/23; 21.7%), back arching (4/23; 17.4%), and gagging (1/23; 4.3%). The characteristics of our study are shown in Table 1 . There were 10 (43.5%) term infants and 13 (56.5%) preterm infants. The duration between BRUE presentation and endoscopy (mean SD) was 37.74 43.91 days, with before, during, and after BRUE presentation being 7/23 (30%), 7/23 (30%), and 9/23 (40%), respectively.
In addition, of the 96 infants who did not undergo endoscopy, 49 (51%) were male, with a mean age at BRUE presentation of 2.27 2.38 months. Most were Caucasians (54/96; 56%), and 42/96 (44%) were AfricanAmerican infants. The mean gestational age was 36.02 3.85 weeks; 65/96 (67.7%) were term and 31/96 (32.3%) were preterm infants. We selected the racematched/sex-matched/term-matched/preterm-matched controls in our 23 control patients. The demographics of the 23 infants who did not undergo endoscopy (control group) are shown in Tables 1 and 2 . Moreover, there were no significant differences between the two groups regarding age, gestational age, number of gestations, number of abortions, birth weight, weight, length, and hospitalized duration. We also compared the prenatal, natal, and postnatal risk factors between the endoscopic and nonendoscopic groups, as shown in Table 2 .
Endoscopic and histologic findings Lymphonodular hyperplasia (LNH, 13/23; 56.5%) and erosions in the rectosigmoid colon (4/23; 17.4%) were the two most common pathologic findings at endoscopy (Fig. 1) . Moreover, our study showed normal endoscopic findings in the stomach and duodenum. One of our patients' did not have biopsies taken during endoscopy. Therefore, we included 22 histologic patients in our study. Eosinophilia in the rectosigmoid colon (20/22; 91%) and eosinophilia in the duodenum (19/22; 86.4%) were the two most common pathologic findings. Interestingly, our study showed normal endoscopic findings (100%) in the duodenum; however, histologic findings revealed duodenal eosinophilia (19/22; 86.4%). Moreover, we found normal endoscopic findings (21/23; 91%) and erythema (2/23; 9%) in esophagus; however, histologic findings showed normal histology (15/22; 68%), eosinophilia (4/22; 18%), and GER disease (3/22; 14%) in esophagus (Fig. 2) .
We demonstrated the relationship between infants who were diagnosed with MSPI before the BRUE episode and the endoscopic finding of LNH was not significant (P = 0.656). However, there was a significant correlation between infants who were diagnosed with MSPI before the BRUE episode and histologic findings of eosinophilia (P = 0.015).
We compared the difference in characteristics between LNH and non-LNH (Table 3) . We found the proportion of females in the LNH group was significantly higher than in non-LNH group. Otherwise, we did not find any significant differences in age, gestational age, birth weight, weight and length at BRUE presentation, hospitalization duration, preterm/term, and hypoallergenic/nonhypoallergenic formula between LNH and non-LNH (Table 3) . We also compared the differences in characteristics between eosinophilia and noneosinophilia (Table 3 ) and found no significant differences in characteristics between the groups. As there were only two patients in the noneosinophilia group, we might not have a large enough sample size to detect the potential differences. For example, in the noneosinophilia group, 100% of the infants were preterm at birth, whereas in the eosinophilia, the percentage is only 55%. Further studies with larger sample sizes are needed to verify these potential differences.
Discussion
An association between GER and cow milk hypersensitivity was observed in infants. Nielsen et al. [3] reported that there was a GER and cow milk hypersensitivity association in 10 of 17 patients with severe GER.
Endoscopic findings of the rectum and colon in food protein-induced enterocolitis syndrome include erythema, increased hyperplasia, and multiple erosions mimicking infectious colitis in severe cases [12] . One review article of allergic colitis in infants reported 225/314 (71.6%) showed friability and erosions of the colonic mucosa at colonoscopy or rectosigmoidoscopy and 236/264 (89.3%) showed eosinophil infiltrations in the colonic mucosa on biopsies [13] . LNH in the rectosigmoid colon has been described as a sign of food allergy in children. Kokkonen [14] reported that duodenal LNH is a characteristic endoscopic finding associated with food Endoscopic findings in infants with BRUE Jarasvaraparn et al. www.eurojgh.comallergy, as seen commonly in infants. In contrast, our study showed LNH was more common in the rectosigmoid colon rather than the duodenum. Interestingly, patients with duodenal LNH mostly present a local reaction of delayed-type food hypersensitivity, which is not shown as atopic allergy by skin prick test or elevated serum IgE [15] . In addition, 55% with LNH of the colon showed concomitant LNH in the duodenal bulb [16] . Thus, colonic LNH is a sensitive endoscopic finding of food hypersensitivity, most likely related to a cellmediated immune response. However, our study showed no concomitant LNH of duodenum and rectosigmoid colon, even though eosinophilic infiltrates were found in intestinal biopsies from both regions. This histologic finding supports the importance of obtaining mucosal biopsies in the evaluation of these patients. One South Korean study included 38 children with food protein-induced proctocolitis who underwent sigmoidoscopy for evaluation of rectal bleeding. Endoscopy showed LNH in 94.7% of patients and 97.4% had eosinophil counts more than or equal to 6 high power field in histologic assessment of the rectosigmoid mucosa [17] , which was similar to our histologic findings. One descriptive study of 116 children with suspected CMPA who underwent an EGD and flexible sigmoidoscopy demonstrated that the rectum had the largest numbers of eosinophils, followed by the duodenum [18] as similar to our study. Interestingly, Augustin et al. [19] reported no significant difference in eosinophil numbers between patients with CMPA and those in the control group.
Moreover, Hwang et al. [17] reported exclusive breastmilk feeding in 94.7% of their patients at the onset of symptoms of food protein-induced proctocolitis, whereas only 5.3% of their patients were formula fed or mixed fed, which differs from our study (only 13% breastfeeding). A significant proportion of our patient population was previously changed to a hypoallergenic formula before endoscopic evaluation (11/23; 47.8%).
One prospective study of 30 infants with MSPI and a history of weight loss and persistent allergic symptoms while on extensively hydrolyzed formula showed improved in weight gain after 12 weeks of amino acidbased formula feeding [20] . Moreover, extensively hydrolyzed formulas and amino acid-based formulas have been shown to improve gut barrier function [21] . Dietary management of cow's milk protein intolerance usually starts with an extensively hydrolyzed infant formula. However, for infants with extremely severe or lifethreatening symptoms, an amino acid-based formula may be used as the first management [10] . There are no evidence-based guidelines for the diagnostic evaluation of infants with higher risk BRUE. The endoscopic and histologic findings alone are nonspecific and not helpful to diagnose underlying conditions associated with BRUE. These procedures should be interpreted in the context of medical history, physical examination, and laboratory tests. The diagnostic yields of these endoscopic and histologic findings are higher for diagnoses other than MSPI. Clinical manifestations of food allergy, especially MSPI in BRUE infants, need to be known to avoid errors in diagnostic orientation and therapy, which may be responsible for worsened symptoms or recurrences. We speculate that MSPI may be associated with BRUE because infants with MSPI can have symptoms of vomiting and retching that disrupt the normal gastric motor activity and can lead to apnea or cyanosis.
There are limitations in our study. First, this was a retrospective study, which could be subject to bias and incomplete/missing data. Second, our study had a small patient pool including only 23 endoscopic infants and 22 histologic infants.
Conclusion
To our knowledge, this is the first study of the characteristics of endoscopic and histologic findings in infants with higher risk BRUE who subsequently underwent evaluation for gastrointestinal symptoms. The present study revealed that rectosigmoid LNH and eosinophilia were the most common findings from endoscopic and histopathologic evaluations. Although there is no proof of association of higher risk BRUE and MSPI, inclusion of MSPI in the differential diagnosis for higher risk BRUE infants may be warranted.
